Camlin Fine Sciences Limited (CFSL) disclosed that it has received clearance from the French Stock Markets Authority (AMF) for its mandatory tender offer for the remaining shares of Vinpai (ISIN: FR001400AXT1; mnémonique: ALVIN) on Euronext Growth Paris.

Current Ownership Structure

As of June 18, 2026, CFSL holds 83.82% of Vinpai's share capital and 80.85% of its voting rights. This follows the company's previous acquisition completed on November 27, 2025, where CFSL acquired a majority stake in Vinpai representing 78.68% of share capital and 84.89% of voting rights through a contribution in kind at a price of EUR 3.60 per Vinpai share (the "Block Acquisition").

Tender Offer Details

The mandatory tender offer (simplified cash tender offer share capital - offre publique d'achat simplifiée or OPAS) is for the remaining shares of Vinpai's share capital not held by CFSL. The offer price is set at EUR 3.60 per Vinpai share, which is the same price as the previous Block Acquisition.

Regulatory Compliance and Documentation

The AMF board issued its clearance decision on June 18, 2026. In accordance with Article 231-28 of the AMF General Regulation, the following documents have been made available to the public:

  • Offer Document detailing the timetable and terms and conditions of the OPAS
  • Other Information Document containing information about the legal, financial and accounting characteristics of CFSL

These documents are available on the websites of the AMF (www.amf-france.org), Camlin Fine Sciences Limited (www.camlinfs.com), and Vinpai (https://vinpai-finance.com/fr/).

Historical Context

The disclosure references a previous press release from Vinpai on October 20, 2025, regarding the conversion of convertible bonds that allowed CFSL to subscribe to 1,100,000 new ordinary shares of Vinpai.

Company Contacts

For further information, investors can contact Camlin Fine Sciences Limited at corporate@camlinfs.com or telephone +91 22 6700 1000 Ext. 402.

Legal Advisors

Fontaine Avocats served as the legal advisor for this transaction.

Distribution Restrictions

The press release contains extensive disclaimers regarding distribution restrictions, noting that it cannot be published, distributed or transmitted in the United States of America, Australia, Canada, South Africa or Japan. The document constitutes an advertisement and not a prospectus under the EU Prospectus Regulation.